Skip to main content
Clinical Trials/JPRN-UMIN000024707
JPRN-UMIN000024707
Completed
未知

The study of the response to the chemotherapy using S-1 and CDGP for p16 positive/p53 negative oropharnygeal squamous cell carcinoma - Chemotherapy for P16+/p53- OPSCC

Kobe City Medical Center General Hospital, Head and Neck Department0 sites50 target enrollmentDecember 1, 2016

Overview

Phase
未知
Intervention
Not specified
Conditions
oropharyngeal squamous cell carcinoma
Sponsor
Kobe City Medical Center General Hospital, Head and Neck Department
Enrollment
50
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2016
End Date
January 1, 2020
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kobe City Medical Center General Hospital, Head and Neck Department

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • The patients with any distant metastasis The patients who are pregnant or possibly pregnant The patients who have a history of surgery or radiation in the oropharynx The patients whose general conditions are too poor for chemotherapy The patients with some conditions which may disturb safety transoral surgery, such as under strong anticoagulants, with severe trismus and so on The patients who are judged to be inappropriate for the study

Outcomes

Primary Outcomes

Not specified

Similar Trials